http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20000030021-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44ad222cd955bf8f2ac30a738271f6aa |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-81 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 1997-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f4ec5abd9e63b4e4f09fe06f6db2ee4 |
publicationDate | 2000-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20000030021-A |
titleOfInvention | USE OF A MELANOMA DIFFERENTIATION ASSOCIATED GENE(mda-7) FOR REVERSING A CANCEROUS PHENOTYPE |
abstract | The present invention provides a method for converting a cancer phenotype of cancer cells, comprising introducing a nucleic acid comprising a melanoma differentiation related gene (mda-7) into the cell under conditions that allow expression of the gene for converting the cancer phenotype of the cell. do. The present invention provides a method of converting a cancer phenotype of cancer cells in an individual by introducing the above-described nucleic acid into cancer cells of the individual.n n n The invention also provides a method of converting a cancer phenotype of a cancer cell by introducing a gene product of a melanoma differentiation related gene (mda-7) into the cancer cell to convert the cancer phenotype of the cell. It provides a method of introducing a product of the gene into cancer cells of the individual to switch the cancer phenotype of cancer cells in the individual.n n n The present invention also has a large amount of nucleic acid and pharmaceutically acceptable carriers, including melanoma differentiation related genes (mda-7), which are effective in converting cancer phenotypes of cancer cells. It provides a pharmaceutical composition having the above-mentioned large amount of gene products and pharmaceutically acceptable carriers effective for converting. |
priorityDate | 1996-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 497.